Haleon UK Holdings Limited

Company Name	Haleon UK Holdings Limited
Company Status	Active
Company Number	08998608
Category	Private Limited Company
Incorporation Date	15 April 2014(10 years ago)
Previous Names	Leo Constellation Limited and Glaxosmithkline Consumer Healthcare Holdings Limited

Business Activity

Section M	Professional, scientific and technical activities
SIC 7415	Holding Companies including Head Offices
SIC 70100	Activities of head offices

Directors

Director Name	Mr Mariano Jesus Godino Escolar
Date of Birth	December 1978 (Born 45 years ago)
Nationality	British
Status	Current
Appointed	23 May 2022(8 years, 1 month after company formation)
Appointment Duration	1 year, 11 months
Role	Accountant
Country of Residence	United Kingdom
Correspondence Address	Building 5, First Floor The Heights Weybridge KT13 0NY

Director Name	Mr Scott Christopher Bourgeois
Date of Birth	March 1978 (Born 46 years ago)
Nationality	British,American
Status	Current
Appointed	18 July 2022(8 years, 3 months after company formation)
Appointment Duration	1 year, 9 months
Role	Company Director
Country of Residence	England
Correspondence Address	Building 5, First Floor The Heights Weybridge KT13 0NY

Director Name	Haleon UK Corporate Secretary Limited (Corporation)
Status	Current
Appointed	18 July 2022(8 years, 3 months after company formation)
Appointment Duration	1 year, 9 months
Correspondence Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	Haleon UK Corporate Director Limited (Corporation)
Status	Current
Appointed	18 July 2022(8 years, 3 months after company formation)
Appointment Duration	1 year, 9 months
Correspondence Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	GSK Consumer Healthcare Holdings (No.8) Limited (Corporation)
Status	Current
Appointed	18 July 2022(8 years, 3 months after company formation)
Appointment Duration	1 year, 9 months
Correspondence Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	GSK Consumer Healthcare Holdings (No.4) Limited (Corporation)
Status	Current
Appointed	18 July 2022(8 years, 3 months after company formation)
Appointment Duration	1 year, 9 months
Correspondence Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	Mrs Victoria Anne Whyte
Date of Birth	April 1968 (Born 56 years ago)
Nationality	British
Status	Resigned
Appointed	15 April 2014(same day as company formation)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Paul Frederick Blackburn
Date of Birth	October 1954 (Born 69 years ago)
Nationality	British
Status	Resigned
Appointed	15 April 2014(same day as company formation)
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Simon Paul Dingemans
Date of Birth	April 1963 (Born 61 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	4 years, 2 months (resigned 08 May 2019)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	David Simon Redfern
Date of Birth	July 1966 (Born 57 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	4 years, 6 months (resigned 03 September 2019)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Brian James McNamara
Date of Birth	March 1966 (Born 58 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	4 years, 6 months (resigned 03 September 2019)
Role	Head Of Americas And Europe
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Ms Emma Natasha Walmsley
Date of Birth	June 1969 (Born 54 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	3 years, 3 months (resigned 04 June 2018)
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Dr Susanne Schaffert
Date of Birth	January 1967 (Born 57 years ago)
Nationality	German
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	3 years, 2 months (resigned 24 May 2018)
Role	Head Of Region Europe For Novartis Oncology
Country of Residence	Italy
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Roger Lidderdale Scarlett-Smith
Date of Birth	November 1959 (Born 64 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	1 year, 6 months (resigned 06 September 2016)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Jonathan Wilson Box
Date of Birth	March 1963 (Born 61 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	2 years, 7 months (resigned 30 September 2017)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Marvelle Elizabeth Sullivan Berchtold
Date of Birth	March 1979 (Born 45 years ago)
Nationality	American
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	2 years, 3 months (resigned 02 June 2017)
Role	Finance/M & A
Country of Residence	Switzerland
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Sir Andrew Philip Witty
Date of Birth	August 1964 (Born 59 years ago)
Nationality	British
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	2 years (resigned 31 March 2017)
Role	CEO
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Steven Loedwijk Margareta Katrien Baert
Date of Birth	September 1974 (Born 49 years ago)
Nationality	Belgian
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	3 years, 2 months (resigned 24 May 2018)
Role	Chief Financial Officer
Country of Residence	Switzerland
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Harry Werner Kirsch
Date of Birth	March 1965 (Born 59 years ago)
Nationality	German
Status	Resigned
Appointed	02 March 2015(10 months, 3 weeks after company formation)
Appointment Duration	3 years, 2 months (resigned 24 May 2018)
Role	Chief Financial Officer
Country of Residence	Switzerland
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	John Richard Slater
Date of Birth	December 1977 (Born 46 years ago)
Nationality	British
Status	Resigned
Appointed	06 September 2016(2 years, 4 months after company formation)
Appointment Duration	1 year, 9 months (resigned 04 June 2018)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Roger Connor
Date of Birth	December 1969 (Born 54 years ago)
Nationality	British
Status	Resigned
Appointed	03 April 2017(2 years, 11 months after company formation)
Appointment Duration	1 year, 2 months (resigned 04 June 2018)
Role	President Gms
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Augusto Lima
Date of Birth	March 1975 (Born 49 years ago)
Nationality	American
Status	Resigned
Appointed	06 June 2017(3 years, 1 month after company formation)
Appointment Duration	11 months, 3 weeks (resigned 24 May 2018)
Role	Lawyer
Country of Residence	Switzerland
Correspondence Address	Novertis International Ag Lichtstrasse 35 Basel 4056

Director Name	Mr Tobias Hestler
Date of Birth	April 1972 (Born 52 years ago)
Nationality	German,Swiss
Status	Resigned
Appointed	01 October 2017(3 years, 5 months after company formation)
Appointment Duration	2 years, 3 months (resigned 31 December 2019)
Role	Chief Financial Officer
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Iain James Mackay
Date of Birth	October 1961 (Born 62 years ago)
Nationality	British
Status	Resigned
Appointed	08 April 2019(4 years, 11 months after company formation)
Appointment Duration	4 months, 4 weeks (resigned 03 September 2019)
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Adam Walker
Date of Birth	November 1967 (Born 56 years ago)
Nationality	British
Status	Resigned
Appointed	02 September 2019(5 years, 4 months after company formation)
Appointment Duration	2 years, 10 months (resigned 18 July 2022)
Role	Svp Group Financial Controller
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mrs Ciara Martha Lynch
Date of Birth	July 1968 (Born 55 years ago)
Nationality	Irish
Status	Resigned
Appointed	02 March 2020(5 years, 10 months after company formation)
Appointment Duration	2 years, 4 months (resigned 18 July 2022)
Role	Accountant
Country of Residence	England
Correspondence Address	980 Great West Road Brentford TW8 9GS

Secretary Name	Edinburgh Phamaceutical Industries Limited (Corporation)
Status	Resigned
Appointed	27 February 2015(10 months, 2 weeks after company formation)
Appointment Duration	7 years, 4 months (resigned 18 July 2022)
Correspondence Address	Edinburgh Phamaceutical Industries Limited Shewalt Irvine Ayrshire KA11 5AP Scotland

Director Name	The Wellcome Foundation Limited (Corporation)
Status	Resigned
Appointed	02 September 2019(5 years, 4 months after company formation)
Appointment Duration	2 years, 10 months (resigned 18 July 2022)
Correspondence Address	Gsk House Corporate Secretariat 980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Resigned
Appointed	02 September 2019(5 years, 4 months after company formation)
Appointment Duration	2 years, 10 months (resigned 18 July 2022)
Correspondence Address	Edinburgh Pharmaceutical Industries Limited Shewal Irvine Ayreshire KA11 5AP Scotland

Contact

Website	gsk.com
Telephone	01280 000000
Telephone region	Buckingham

Location

Registered Address	Building 5, First Floor The Heights Weybridge KT13 0NY
Region	South East
Constituency	Runnymede and Weybridge
County	Surrey
Ward	Weybridge St George's Hill
Built Up Area	Greater London
Address Matches	Over 20 other UK companies use this postal address

Shareholders

63.5k at £1	Setfirst Limited 63.50% Ordinary A
33.9k at £1	Novartis Holding Ag 33.85% Ordinary B
2.7k at £1	Novartis Finance Corporation 2.65% Ordinary B

Financials

Year	2014
Net Worth	-£3,090
Current Liabilities	£4,313

Accounts

Latest Accounts	31 December 2022 (1 year, 3 months ago)
Next Accounts Due	30 September 2024 (5 months from now)
Accounts Category	Full
Accounts Year End	31 December

Returns

Latest Return	14 September 2023 (7 months, 2 weeks ago)
Next Return Due	28 September 2024 (5 months from now)

Filing History

20 October 2023	Company name changed glaxosmithkline consumer healthcare holdings LIMITED\certificate issued on 20/10/23 NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2023-10-12 (3 pages)
2 October 2023	Full accounts made up to 31 December 2022 (39 pages)
14 September 2023	Confirmation statement made on 14 September 2023 with updates (4 pages)
15 May 2023	Secretary's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited on 31 March 2023 (1 page)
15 May 2023	Director's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited on 31 March 2023 (1 page)
15 May 2023	Director's details changed for Haleon Uk Corporate Director Limited on 31 March 2023 (1 page)
15 May 2023	Director's details changed for Gsk Consumer Healthcare Holdings (No.4) Limited on 31 March 2023 (1 page)
8 February 2023	Cessation of Haleon Plc as a person with significant control on 6 February 2023 (1 page)
8 February 2023	Notification of Haleon Intermediate Holdings Limited as a person with significant control on 6 February 2023 (2 pages)
16 December 2022	Change of details for Haleon Plc as a person with significant control on 9 December 2022 (2 pages)
10 October 2022	Confirmation statement made on 20 September 2022 with updates (6 pages)
15 August 2022	Director's details changed for Mr Scott Christopher Bourgeois on 18 July 2022 (2 pages)
29 July 2022	Notification of Haleon Plc as a person with significant control on 15 July 2022 (2 pages)
29 July 2022	Cessation of Gsk Plc as a person with significant control on 15 July 2022 (1 page)
20 July 2022	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 18 July 2022 (1 page)
19 July 2022	Appointment of Gsk Consumer Healthcare Holdings (No.8) Limited as a director on 18 July 2022 (2 pages)
19 July 2022	Appointment of Gsk Consumer Healthcare Holdings (No.4) Limited as a director on 18 July 2022 (2 pages)
19 July 2022	Termination of appointment of Edinburgh Phamaceutical Industries Limited as a secretary on 18 July 2022 (1 page)
19 July 2022	Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to Building 5, First Floor the Heights Weybridge KT13 0NY on 19 July 2022 (1 page)
19 July 2022	Appointment of Gsk Consumer Healthcare Holdings (No.8) Limited as a secretary on 18 July 2022 (2 pages)
19 July 2022	Termination of appointment of the Wellcome Foundation Limited as a director on 18 July 2022 (1 page)
19 July 2022	Termination of appointment of Ciara Martha Lynch as a director on 18 July 2022 (1 page)
19 July 2022	Termination of appointment of Adam Walker as a director on 18 July 2022 (1 page)
19 July 2022	Appointment of Mr Scott Christopher Bourgeois as a director on 18 July 2022 (2 pages)
15 June 2022	Full accounts made up to 31 December 2021 (34 pages)
7 June 2022	Memorandum and Articles of Association (33 pages)
7 June 2022	Statement of capital following an allotment of shares on 30 May 2022 GBP 5,659,882,811 (7 pages)
31 May 2022	Solvency Statement dated 30/05/22 (3 pages)
31 May 2022	Statement of capital on 31 May 2022 GBP 63,501 (3 pages)
31 May 2022	Resolutions RES10 ‐ Resolution of allotment of securities RES06 ‐ Resolution of reduction in issued share capital RES01 ‐ Resolution of adoption of Articles of Association (4 pages)
31 May 2022	Statement by Directors (3 pages)
27 May 2022	Change of details for Gsk Plc as a person with significant control on 16 May 2022 (2 pages)
26 May 2022	Change of details for Glaxosmithkline Plc as a person with significant control on 16 May 2022 (2 pages)
26 May 2022	Change of details for Gsk Plc as a person with significant control on 16 May 2022 (2 pages)
26 May 2022	Change of details for Gsk Plc as a person with significant control on 16 May 2022 (2 pages)
24 May 2022	Appointment of Mr Mariano Jesus Godino Escolar as a director on 23 May 2022 (2 pages)
31 March 2022	Particulars of variation of rights attached to shares (3 pages)
31 March 2022	Change of share class name or designation (2 pages)
29 March 2022	Resolutions RES12 ‐ Resolution of varying share rights or name RES01 ‐ Resolution of adoption of Articles of Association (1 page)
24 March 2022	Memorandum and Articles of Association (33 pages)
20 September 2021	Confirmation statement made on 20 September 2021 with no updates (3 pages)
2 July 2021	Full accounts made up to 31 December 2020 (34 pages)
8 October 2020	Confirmation statement made on 26 September 2020 with updates (5 pages)
11 June 2020	Full accounts made up to 31 December 2019 (36 pages)
23 March 2020	Termination of appointment of Tobias Hestler as a director on 31 December 2019 (1 page)
18 March 2020	Appointment of Mrs Ciara Martha Lynch as a director on 2 March 2020 (2 pages)
26 September 2019	Confirmation statement made on 26 September 2019 with updates (4 pages)
11 September 2019	Cessation of Glaxosmithkline Holdings Limited as a person with significant control on 24 June 2019 (1 page)
11 September 2019	Notification of Glaxosmithkline Holdings Limited as a person with significant control on 24 June 2019 (2 pages)
11 September 2019	Notification of Glaxosmithkline Plc as a person with significant control on 24 June 2019 (2 pages)
5 September 2019	Termination of appointment of Brian Mcnamara as a director on 3 September 2019 (1 page)
5 September 2019	Termination of appointment of David Simon Redfern as a director on 3 September 2019 (1 page)
5 September 2019	Cessation of Glaxosmithkline Finance Plc as a person with significant control on 24 June 2019 (1 page)
5 September 2019	Termination of appointment of Iain James Mackay as a director on 3 September 2019 (1 page)
5 September 2019	Appointment of Mr Adam Walker as a director on 2 September 2019 (2 pages)
4 September 2019	Appointment of Edinburgh Pharmaceutical Industries Limited as a director on 2 September 2019 (2 pages)
4 September 2019	Appointment of The Wellcome Foundation Limited as a director on 2 September 2019 (2 pages)
10 June 2019	Change of share class name or designation (2 pages)
10 June 2019	Resolutions RES01 ‐ Resolution of adoption of Articles of Association (33 pages)
10 June 2019	Statement of capital following an allotment of shares on 23 May 2019 GBP 63,501 (4 pages)
5 June 2019	Notification of Glaxosmithkline Finance Plc as a person with significant control on 31 May 2019 (2 pages)
5 June 2019	Cessation of Setfirst Limited as a person with significant control on 31 May 2019 (1 page)
13 May 2019	Termination of appointment of Simon Paul Dingemans as a director on 8 May 2019 (1 page)
18 April 2019	Confirmation statement made on 15 April 2019 with updates (4 pages)
11 April 2019	Full accounts made up to 31 December 2018 (32 pages)
10 April 2019	Appointment of Mr Iain James Mackay as a director on 8 April 2019 (2 pages)
13 June 2018	Termination of appointment of Roger Connor as a director on 4 June 2018 (1 page)
13 June 2018	Termination of appointment of Emma Natasha Walmsley as a director on 4 June 2018 (1 page)
13 June 2018	Termination of appointment of John Richard Slater as a director on 4 June 2018 (1 page)
11 June 2018	Cessation of Novartis Holding Ag as a person with significant control on 1 June 2018 (3 pages)
11 June 2018	Change of details for Setfirst Limited as a person with significant control on 1 June 2018 (5 pages)
1 June 2018	Termination of appointment of Augusto Lima as a director on 24 May 2018 (1 page)
1 June 2018	Statement of capital on 1 June 2018 GBP 63,500 (3 pages)
1 June 2018	Termination of appointment of Susanne Schaffert as a director on 24 May 2018 (1 page)
1 June 2018	Solvency Statement dated 25/05/18 (2 pages)
1 June 2018	Termination of appointment of Steven Loedwijk Margareta Katrien Baert as a director on 24 May 2018 (1 page)
1 June 2018	Resolutions RES13 ‐ Cancellation of share premium account 25/05/2018 RES06 ‐ Resolution of reduction in issued share capital (5 pages)
1 June 2018	Termination of appointment of Harry Werner Kirsch as a director on 24 May 2018 (1 page)
1 June 2018	Statement by Directors (2 pages)
25 May 2018	Statement of capital on 25 May 2018 GBP 100,000 ANNOTATION Clarification This document is a second filing of the SH19 registered on 16/03/2016. (4 pages)
23 May 2018	Second filing of the annual return made up to 15 April 2015 (27 pages)
22 May 2018	Second filing of a statement of capital following an allotment of shares on 2 March 2015 GBP 100,000.00 (7 pages)
22 May 2018	Second filing of the annual return made up to 15 April 2016 (27 pages)
18 April 2018	Full accounts made up to 31 December 2017 (27 pages)
16 April 2018	Confirmation statement made on 15 April 2018 with no updates (3 pages)
13 October 2017	Termination of appointment of Jonathan Wilson Box as a director on 30 September 2017 (1 page)
13 October 2017	Termination of appointment of Jonathan Wilson Box as a director on 30 September 2017 (1 page)
5 October 2017	Appointment of Tobias Hestler as a director on 1 October 2017 (3 pages)
5 October 2017	Appointment of Tobias Hestler as a director on 1 October 2017 (3 pages)
7 July 2017	Termination of appointment of Andrew Philip Witty as a director on 31 March 2017 (1 page)
7 July 2017	Termination of appointment of Andrew Philip Witty as a director on 31 March 2017 (1 page)
4 July 2017	Appointment of Augusto Lima as a director on 6 June 2017 (3 pages)
4 July 2017	Appointment of Augusto Lima as a director on 6 June 2017 (3 pages)
19 June 2017	Termination of appointment of Marvelle Elizabeth Sullivan Berchtold as a director on 2 June 2017 (1 page)
19 June 2017	Termination of appointment of Marvelle Elizabeth Sullivan Berchtold as a director on 2 June 2017 (1 page)
26 April 2017	Confirmation statement made on 15 April 2017 with updates (6 pages)
26 April 2017	Confirmation statement made on 15 April 2017 with updates (6 pages)
22 April 2017	Appointment of Roger Connor as a director on 3 April 2017 (3 pages)
22 April 2017	Appointment of Roger Connor as a director on 3 April 2017 (3 pages)
10 April 2017	Full accounts made up to 31 December 2016 (25 pages)
10 April 2017	Full accounts made up to 31 December 2016 (25 pages)
19 October 2016	Appointment of John Richard Slater as a director on 6 September 2016 (3 pages)
19 October 2016	Appointment of John Richard Slater as a director on 6 September 2016 (3 pages)
22 September 2016	Full accounts made up to 31 December 2015 (23 pages)
22 September 2016	Full accounts made up to 31 December 2015 (23 pages)
21 September 2016	Termination of appointment of Roger Lidderdale Scarlett-Smith as a director on 6 September 2016 (1 page)
21 September 2016	Termination of appointment of Roger Lidderdale Scarlett-Smith as a director on 6 September 2016 (1 page)
19 April 2016	Annual return made up to 15 April 2016 with a full list of shareholders Statement of capital on 2016-04-19 GBP 100,000 ANNOTATION Clarification a second filed AR01 was registered on 22/05/2018. (17 pages)
19 April 2016	Annual return made up to 15 April 2016 with a full list of shareholders Statement of capital on 2016-04-19 GBP 100,000 (15 pages)
16 March 2016	Statement of capital on 16 March 2016 GBP 100,000.00 ANNOTATION Clarification a second filed SH19 was registered on 25/05/2018. (5 pages)
16 March 2016	Statement of capital on 16 March 2016 GBP 100,000.00 (4 pages)
16 March 2016	Solvency Statement dated 10/03/16 (3 pages)
16 March 2016	Resolutions RES13 ‐ The share premium account be reduced. 10/03/2016 (5 pages)
16 March 2016	Resolutions RES13 ‐ The share premium account be reduced. 10/03/2016 RES13 ‐ The share premium account be reduced. 10/03/2016 (5 pages)
16 March 2016	Statement by Directors (3 pages)
16 March 2016	Solvency Statement dated 10/03/16 (3 pages)
16 March 2016	Statement by Directors (3 pages)
9 January 2016	Second filing of SH01 previously delivered to Companies House ANNOTATION Clarification Second filing SH01 for allotment date 25/02/2015. (6 pages)
9 January 2016	Second filing of SH01 previously delivered to Companies House ANNOTATION Clarification Second filing SH01 for allotment date 13/02/2015. (16 pages)
9 January 2016	Second filing of SH01 previously delivered to Companies House ANNOTATION Clarification Second filing SH01 for allotment date 25/02/2015. (6 pages)
9 January 2016	Second filing of SH01 previously delivered to Companies House ANNOTATION Clarification Second filing SH01 for allotment date 13/02/2015. (16 pages)
31 December 2015	Statement of capital following an allotment of shares on 20 February 2015 GBP 60,003 (4 pages)
31 December 2015	Statement of capital following an allotment of shares on 20 February 2015 GBP 60,003 (4 pages)
17 June 2015	Full accounts made up to 31 December 2014 (13 pages)
17 June 2015	Full accounts made up to 31 December 2014 (13 pages)
29 May 2015	Annual return made up to 15 April 2015 with a full list of shareholders Statement of capital on 2015-05-29 GBP 100,000 (15 pages)
29 May 2015	Annual return made up to 15 April 2015 with a full list of shareholders Statement of capital on 2015-05-29 GBP 100,000 ANNOTATION Clarification a second filed AR01 was registered on 23/05/2018. (16 pages)
21 May 2015	Statement of capital following an allotment of shares on 2 March 2015 GBP 60,007.00 ANNOTATION Clarification a second filed SH01 was registered on 22/05/2018. (6 pages)
21 May 2015	Statement of capital following an allotment of shares on 2 March 2015 GBP 60,007.00 (5 pages)
21 May 2015	Statement of capital following an allotment of shares on 2 March 2015 GBP 60,007.00 (5 pages)
20 May 2015	Change of share class name or designation (2 pages)
20 May 2015	Change of share class name or designation (2 pages)
24 April 2015	Appointment of Dr Susanne Schaffert as a director on 2 March 2015 (3 pages)
24 April 2015	Appointment of Dr Susanne Schaffert as a director on 2 March 2015 (3 pages)
24 April 2015	Appointment of Dr Susanne Schaffert as a director on 2 March 2015 (3 pages)
23 April 2015	Appointment of Edinburgh Phamaceutical Industries Limited as a secretary on 27 February 2015 (3 pages)
23 April 2015	Appointment of Edinburgh Phamaceutical Industries Limited as a secretary on 27 February 2015 (3 pages)
13 April 2015	Statement of capital following an allotment of shares on 25 February 2015 GBP 600,005 ANNOTATION Clarification a second filed SH01 was registered on 09/01/2016. (4 pages)
13 April 2015	Statement of capital following an allotment of shares on 27 February 2015 GBP 600,009 (5 pages)
13 April 2015	Statement of capital following an allotment of shares on 27 February 2015 GBP 600,009 (5 pages)
13 April 2015	Statement of capital following an allotment of shares on 25 February 2015 GBP 600,005 ANNOTATION Clarification a second filed SH01 was registered on 09/01/2016. (4 pages)
13 April 2015	Statement of capital following an allotment of shares on 25 February 2015 GBP 600,005 (4 pages)
11 April 2015	Statement of capital following an allotment of shares on 25 February 2015 GBP 600,007 ANNOTATION Clarification a second filed SH01 was registered on 09/01/2016. (4 pages)
11 April 2015	Statement of capital following an allotment of shares on 25 February 2015 GBP 600,007 ANNOTATION Clarification a second filed SH01 was registered on 09/01/2016. (4 pages)
11 April 2015	Statement of capital following an allotment of shares on 25 February 2015 GBP 600,007 (4 pages)
27 March 2015	Appointment of Marvelle Elizabeth Sullivan Berchtold as a director on 2 March 2015 (3 pages)
27 March 2015	Appointment of Steven Loedwijk Margareta Katrien Baert as a director on 2 March 2015 (3 pages)
27 March 2015	Appointment of Marvelle Elizabeth Sullivan Berchtold as a director on 2 March 2015 (3 pages)
27 March 2015	Appointment of Marvelle Elizabeth Sullivan Berchtold as a director on 2 March 2015 (3 pages)
27 March 2015	Appointment of Steven Loedwijk Margareta Katrien Baert as a director on 2 March 2015 (3 pages)
27 March 2015	Appointment of Steven Loedwijk Margareta Katrien Baert as a director on 2 March 2015 (3 pages)
20 March 2015	Resolutions RES01 ‐ Resolution of adoption of Articles of Association (36 pages)
20 March 2015	Resolutions RES01 ‐ Resolution of adoption of Articles of Association (36 pages)
13 March 2015	Appointment of Sir Andrew Philip Witty as a director on 2 March 2015 (3 pages)
13 March 2015	Appointment of Sir Andrew Philip Witty as a director on 2 March 2015 (3 pages)
13 March 2015	Appointment of Sir Andrew Philip Witty as a director on 2 March 2015 (3 pages)
10 March 2015	Termination of appointment of Victoria Anne Whyte as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Victoria Anne Whyte as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Paul Frederick Blackburn as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Victoria Anne Whyte as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Paul Frederick Blackburn as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 2 March 2015 (2 pages)
10 March 2015	Termination of appointment of Paul Frederick Blackburn as a director on 2 March 2015 (2 pages)
9 March 2015	Appointment of Jonathan Wilson Box as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Roger Lidderdale Scarlett-Smith as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Roger Lidderdale Scarlett-Smith as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Roger Lidderdale Scarlett-Smith as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of David Redfern as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Brian Mcnamara as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Simon Dingemans as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Emma Natasha Walmsley as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Brian Mcnamara as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Brian Mcnamara as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Jonathan Wilson Box as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Emma Natasha Walmsley as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Simon Dingemans as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Emma Natasha Walmsley as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Harry Werner Kirsch as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Harry Werner Kirsch as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of David Redfern as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Harry Werner Kirsch as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Jonathan Wilson Box as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of David Redfern as a director on 2 March 2015 (3 pages)
9 March 2015	Appointment of Simon Dingemans as a director on 2 March 2015 (3 pages)
4 March 2015	Statement of capital following an allotment of shares on 13 February 2015 GBP 60,001 (4 pages)
4 March 2015	Statement of capital following an allotment of shares on 13 February 2015 GBP 60,001 (4 pages)
18 December 2014	Current accounting period shortened from 30 April 2015 to 31 December 2014 (1 page)
18 December 2014	Current accounting period shortened from 30 April 2015 to 31 December 2014 (1 page)
2 October 2014	Company name changed leo constellation LIMITED\certificate issued on 02/10/14 CONNOT ‐ (3 pages)
2 October 2014	Company name changed leo constellation LIMITED\certificate issued on 02/10/14 CONNOT ‐ (3 pages)
15 April 2014	Incorporation (40 pages)
15 April 2014	Incorporation (40 pages)

Haleon UK Holdings Limited

Business Activity

Directors

Contact

Location

Shareholders

Financials

Accounts

Returns

Filing History

Contact Companies London